Oral propylthiouracil for the treatment of resistant plaque psoriasis

Journal of Dermatological Treatment

Volumn 12, Issue 2, 2001, Pages 81-85

  Chowdhury, M M U ^a   Marks, R ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Oral propylthiouracil; Resistant plaque psoriasis

Indexed keywords

PROPYLTHIOURACIL;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CASE REPORT; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; HYPOTHYROIDISM; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MALE; MYALGIA; PRIORITY JOURNAL; PSORIASIS; THYROID FUNCTION TEST;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPYLTHIOURACIL; PSORIASIS;

EID: 0034776212     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/095466301317085354     Document Type: Article

References (15)

1. Antithyroid drugs
2. The effect of antithyroid drugs on B and T cell activity in vitro
3. The effects of antithyroid drugs on intercellular mediators
4. Inhibition of immunoglobulin-secreting cells by antithyroid drugs
5. Propylthiouracil in psoriasis: Results of an open trial
6. Serum ICAM-1 concentrations in patients with psoriasis treated with antithyroid thioureylenes
7. Effect of orally administered antithyroid thioureylenes on PCNA and p53 expression in psoriatic lesions
8. A controlled trial of topical propylthiouracil in the treatment of patients with psoriasis
9. Low-dose oral propylthiouracil in the treatment of plaque psoriasis
10. Expression of parathyroid hormone related protein in normal skin and in tumours of skin and skin appendages
11. The steroid and thyroid hormone receptor superfamily
12. Parathyroid hormone related protein is localized in the granular layer of normal skin and in dermal infiltrates of mycosis fungoides but is absent in psoriatic lesions
13. Propylthiouracil hypersensitivity: Report of two patients with vasculitis and review of the literature
14. Controversial aspects of thyroid disease
15. Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections